Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Evercore ISI analyst Liisa Bayko maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price target ...

On Wednesday, Vertex Pharmaceuticals Incorporated (VRTX) stock saw a decline, ending the day at $470.05 which represents a decrease of $-4.86 or -1.02% from the prior close of $474.91. The stock ...

The pharma market shows promise as gene therapy gains momentum through rapid advancements that address complex diseases and ...

Wells Fargo analyst Mohit Bansal has maintained their bullish stance on VRTX stock, giving a Buy rating yesterday. Mohit Bansal has given his ...

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts ...

Nineteen companies are receiving $21.4 million total in tax incentive awards to create 1,155 new life sciences jobs in ...

In that spirit, let's discuss two companies that meet those criteria: HCA Healthcare ( HCA 2.23%) and Vertex Pharmaceuticals ( VRTX -3.15%). Here's why their stocks could deliver better returns than ...

These pharmaceutical stocks have attractive dividends and valuation upside.

Boston has become world-famous for its booming biotech industry. Over the past 20 years, the city has been buzzing with groundbreaking discoveries, cutting-edge research, and influential biotech ...

New Century Financial Group LLC lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 25.1% during the 3rd quarter, according to its most recent disclosure with ...

Governor Maura Healey on Tuesday announced $21.4 million in tax incentives for life sciences companies that are expected to create 1,155 jobs in the state.